Abstract: According to one embodiment, a semiconductor storage device includes a plurality of electrode films on a substrate, spaced from one another in a first direction. A charge storage film is provided on a side face the electrode films via a first insulating film. A semiconductor film is provided on a side face of the charge storage film via a second insulating film. The charge storage film includes a plurality of insulator regions contacting the first insulating film, a plurality of semiconductor or conductor regions provided between the insulator regions and another insulator region.

Abstract: A machine controller that controls an action of the construction machine; an external operation controller that controls unmanned operation that does not require operation by an operator riding in an operation room, by generating a control signal according to an operation signal received from an outside via a communication terminal, and sending the control signal to the machine controller; an approach permission signaling light that signals permission for a worker to approach the construction machine; and an action request signaling light that signals a request for riding in the operation room and performing a particular action to a nearby worker are provided, and the external operation controller is configured to control the approach permission signaling light to be turned on when it is decided that approach of the worker to the construction machine can be tolerated according to information collected by the machine controller, and also control the action request signaling light to be turned on when it is dec

Abstract: The present invention aims to provide a heterocyclic compound having an AMPA receptor potentiator effect, which is expected to be useful as an agent for the prophylaxis or treatment of depression, Alzheimer's disease, schizophrenia, attention deficit hyperactivity disorder (ADHD) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: Substrates can be suppressed from being separated from supporting grooves. A substrate processing apparatus includes a substrate holding unit and a processing tub. The substrate holding unit is configured to hold multiple substrates. The processing tub is configured to store a processing liquid therein. The substrate holding unit comprises a supporting body, an elevating device and a restriction unit. The supporting body has multiple supporting grooves and is configured to support the multiple substrates with a vertically standing posture from below in the multiple supporting grooves, respectively. The elevating device is configured to move the supporting body between a standby position above the processing tub and a processing position within the processing tub. The restriction unit is configured to be moved up and down along with the supporting body by the elevating device and configured to restrict an upward movement of the substrates with respect to the supporting body.

Abstract: A rotation controlling section of a control unit calculates a maximum thicknesswise difference in a wafer by using a noncontact thickness measuring instrument, and if the maximum thicknesswise difference exceeds a tolerance, relatively changes a rotational speed of a chuck table relative to a rotational speed of a spindle. This can shift a rotational speed ratio, which is a ratio between the rotational speed of the spindle and the rotational speed of the chuck table, from an integer. Therefore, the maximum thicknesswise difference can be made small through spark-out processing. As a result, cyclic variations in thickness value of the wafer are reduced, enabling planarization of a ground surface of the wafer.

Abstract: An anomaly detection method executed by a computer, the anomaly detection method includes identifying, for each of target periods, a prediction value to be a reference for determining whether an anomaly occurs in the target period; identifying a corrected prediction value acquired by correcting the prediction value of a first target period based on the prediction value and a measured values of a second target period before the first target period; setting one of the prediction value and the corrected prediction value corresponding to the first target period as an upper limit value and the other as a lower limit value; and determining whether the anomaly occurs in the first target period by using a reference defined by the upper limit value and the lower limit value.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: Provided is an anomaly detection method implemented by a computer, the anomaly detection method including identifying a time period during which time-series data of a parameter relating to a network have a periodicity, when a first time is within the time period, determining whether the network has an anomaly using a first method based on the time-series data, and when the first time is not within the time period, determining whether the network has an anomaly using a second method different from the first method.

Abstract: The present embodiments are directed, in part, to 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, such as those of Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinson's Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: In both a case where a workpiece is a regular workpiece having a first residual peeling layer on one surface thereof and a case where the workpiece is an adjustment workpiece not having the first residual peeling layer, a wafer having a predetermined thickness is manufactured by grinding opposite surfaces of the workpiece. That is, in the present invention, because the opposite surfaces of the workpiece are ground, wafers can be manufactured from two kinds of workpieces irrespective of whether or not the first residual peeling layer is present on the one surface of the workpiece. Hence, even when two kinds of workpieces are housed in a mixed manner in a first cassette, wafers having the predetermined thickness can be manufactured easily from these workpieces.

Abstract: A data processing device performs clustering time-series data. The data processing device includes a memory, and a processor coupled to the memory and configured to: collect a plurality of pieces of first time-series data that belongs to a target period for clustering; calculate, when the first time-series data contains an outlier that represents a local peak, a degree of anomaly of the outlier, based on second time-series data in a past for a period that corresponds to the first time-series data; determine whether or not the degree of anomaly is equal to or higher than an anomaly standard for the outlier; remove, when the degree of anomaly is equal to or higher than the anomaly standard, the outlier from the first time-series data; and cluster the first time-series data after removing the outlier.

Abstract: The present invention addresses the problem of providing a dissolving agent which improves the solubility of a compound such as curcumin that contains an aromatic ring without changing the structure of this compound. The present invention is a compound which is represented by general formula (1). (In the formula, R1 is an alkyl group having 7 to 24 carbon atoms or an alkenyl group; A1 represents an optionally substituted aryl group; Z1 represents a single bond, an alkylene group having from 1 to 6 carbon atoms, or an alkenylene group having from 2 to 5 carbon atoms; and Z2 represents a divalent linking group.

Abstract: An information processing method for a computer to execute a process includes, acquiring a plurality of pieces of time-series data; calculating an index value that relates to periodicity at a certain time interval for each piece of aggregated time-series data obtained by dividing and aggregating the plurality of pieces of the time-series data in accordance with a certain unit of aggregation; determining the each piece of the aggregated time-series data as an analysis target when the index value satisfies a certain condition; and performing certain analysis processing on the analysis target.

Abstract: A display device includes a plurality of pixel circuits each including: a light-emitting element; a pulse width modulation (PWM) controller configured to control whether to supply current to the light-emitting element; and a constant current controller configured to supply the current to the light-emitting element, wherein the constant current controller, the PWM controller, and the light-emitting element are connected in series between a first power line and a second power line to supply the current to the light-emitting element; and a transistor configured to turn off the light-emitting element during a constant current setting period is provided between the first power line and the constant current controller.

Abstract: A rotation controlling section of a control unit calculates a maximum thicknesswise difference in a wafer by using a noncontact thickness measuring instrument, and if the maximum thicknesswise difference exceeds a tolerance, relatively changes a rotational speed of a chuck table relative to a rotational speed of a spindle. This can shift a rotational speed ratio, which is a ratio between the rotational speed of the spindle and the rotational speed of the chuck table, from an integer. Therefore, the maximum thicknesswise difference can be made small through spark-out processing. As a result, cyclic variations in thickness value of the wafer are reduced, enabling planarization of a ground surface of the wafer.

Abstract: A grinding apparatus including a chuck table for holding a wafer, a grinding unit having a spindle for rotating a grinding wheel, an inclination adjusting unit for adjusting the inclination of the rotation axis of the chuck table with respect to the rotation axis of the spindle, a touch panel, and a control portion. The control portion is adapted to compare the information regarding the target sectional shape input into a target shape input field with the information regarding the present sectional shape input into a present shape input field and then control the inclination adjusting unit to change the inclination of the rotation axis of the chuck table so that the wafer is ground to obtain the target sectional shape of the wafer.

Abstract: The resin composition for plating of the present invention includes: a graft copolymer (A) in which a monomer component (a) including specific amounts of an aromatic vinyl compound (a1), a vinyl cyanide compound (a2), and another vinyl compound (a3) is graft-polymerized on a rubbery polymer; and a polycarbonate resin (P), wherein an amount of resin (P) is 40 to 70% by mass, based on a total mass of the resin composition, a rubber content (X) in copolymer (A) is more than 40% by mass, based on a total mass of copolymer (A), a graft ratio (Y) of copolymer (A) satisfies formula (1): 793e?0.041X?Y?515e?0.041X (1), and a rubber content (Z) in the resin composition is 10 to 18% by mass, based on a total mass of the resin composition.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.